Cargando…

First clinical trial of a MERS coronavirus DNA vaccine

Detalles Bibliográficos
Autores principales:	Yoon, In-Kyu, Kim, Jerome H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2019
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128141/ https://www.ncbi.nlm.nih.gov/pubmed/31351923 http://dx.doi.org/10.1016/S1473-3099(19)30397-4

Ejemplares similares

Triumphs, trials, and tribulations of the global response to MERS coronavirus
por: McNabb, Scott J N, et al.
Publicado: (2014)

Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?
por: Modjarrad, Kayvon, et al.
Publicado: (2020)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014)

Spread of MERS to South Korea and China
por: Hui, David S, et al.
Publicado: (2015)

MERS-CoV: the intermediate host identified?
por: de Wit, Emmie, et al.
Publicado: (2013)

Tracking the transmission and evolution of MERS-CoV
por: Hui, David S
Publicado: (2013)

Treating MERS-CoV during an outbreak
por: Coleman, Christopher M, et al.
Publicado: (2014)

Identification of MERS-CoV in dromedary camels
por: Ferguson, Neil M, et al.
Publicado: (2014)

COVID-19 vaccines: breaking record times to first-in-human trials
por: Kim, Young Chan, et al.
Publicado: (2020)

Super-spreading events of MERS-CoV infection
por: Hui, David S
Publicado: (2016)

MERS-CoV in Africa—an enigma with relevance to COVID-19
por: Perlman, Stanley, et al.
Publicado: (2021)

Dromedary MERS-CoV replicates in human respiratory tissues
por: Reperant, Leslie A, et al.
Publicado: (2014)

Preventive measures against MERS-CoV for Hajj pilgrims
por: Gautret, Philippe, et al.
Publicado: (2013)

Infection control and MERS-CoV in health-care workers
por: Zumla, Alimuddin, et al.
Publicado: (2014)

What can psychiatrists learn from SARS and MERS outbreaks?
por: Sommer, Iris E, et al.
Publicado: (2020)

Universal coronavirus vaccines: the time to start is now
por: Giurgea, Luca T., et al.
Publicado: (2020)

Recent clinical trials inform the future for malaria vaccines
por: Kurtovic, Liriye, et al.
Publicado: (2021)

Predicting the efficacy of new coronavirus vaccines – Are neutralising antibodies enough?
por: Miller, Elizabeth
Publicado: (2022)

Designing circulating tumor DNA-based interventional clinical trials in oncology
por: Araujo, Daniel V., et al.
Publicado: (2019)

SARS-CoV-2 vaccination and phase 1 cancer clinical trials
por: Yap, Timothy A, et al.
Publicado: (2021)

First human efficacy study of a plant-derived influenza vaccine
por: Tregoning, John S
Publicado: (2020)

DNA vaccines join the fight against COVID-19
por: Blakney, Anna K, et al.
Publicado: (2022)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

Emerging Animal Coronaviruses: First SARS and Now MERS
por: Fong, I. W.
Publicado: (2017)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

New international guidance on quality, safety and efficacy of DNA vaccines
por: Beasley, David W. C.
Publicado: (2020)

What can we expect from first-generation COVID-19 vaccines?
por: Peiris, Malik, et al.
Publicado: (2020)

Towards improving clinical management of Middle East respiratory syndrome coronavirus infection
por: Hayden, Frederick G, et al.
Publicado: (2014)

Pharmacological trials for long COVID: first light at the end of the tunnel
por: Buonsenso, Danilo
Publicado: (2022)

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
por: Bird, Sarah, et al.
Publicado: (2021)

COVID-19 vaccine trials should seek worthwhile efficacy
por: Krause, Philip, et al.
Publicado: (2020)

Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
por: Mohsen, Mona O., et al.
Publicado: (2021)

Coronavirus Disease 2019 and Primary Antibody Deficiencies. Comment on Milota et al. Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens 2023, 12, 109
por: Özdemir, Öner
Publicado: (2023)

An immunological autobiography: my year as a COVID-19 vaccine trial participant
por: Kedl, Ross M.
Publicado: (2022)

One world, one health, one virology of the mysterious labyrinth of coronaviruses: the canine coronavirus affair
por: Pratelli, Annamaria, et al.
Publicado: (2021)

The incidence of Coronavirus disease 2019 (COVID-19) among vaccinated healthcare workers (HCWs): evidence for protection from hospitalisation from an Indonesian cohort
por: Kozlakidis, Zisis
Publicado: (2023)

COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA
por: Krantz, Matthew S, et al.
Publicado: (2022)

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Offline: A novel solution to live with coronavirus
por: Horton, Richard
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nhsq4rmjojgb0b17dt02kklpan